创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

WANG Meng, SHEN Aizong. Research Progress of Drug-induced Liver Injury during Pregnancy[J]. Progress in Pharmaceutical Sciences, 2023, 47(2): 101-107. DOI: 10.20053/j.issn1001-5094.2023.02.004
Citation: WANG Meng, SHEN Aizong. Research Progress of Drug-induced Liver Injury during Pregnancy[J]. Progress in Pharmaceutical Sciences, 2023, 47(2): 101-107. DOI: 10.20053/j.issn1001-5094.2023.02.004

Research Progress of Drug-induced Liver Injury during Pregnancy

  • Drug-induced liver injury during pregnancy (DILI), one of the key causes of acute liver failure and even death in pregnant women, seriously impairs maternal and infant outcomes. Nowadays, DILI has received increasing clinical attention due to its uncommon yet serious consequences. The management of DILI faces great challenges due to the lack of studies on the safety of medication during pregnancy, the complex influencing factors, and the difficulty in diagnosis. In this article, the epidemiology, types, influencing factors, common drugs, clinical diagnosis and management of DILI are reviewed to provide a valuable basis for clinical practice.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return